Prime Aventine Team
Our team of highly accomplished PharmDs has years of experience and expertise developing US formulary submission dossiers for a wide range of products across diverse disease states and clinical settings. Because our team members have past experience evaluating products for reimbursement and formulary inclusion from the US payer side of the access equation, we understand the needs of the payer audience and are able to leverage that knowledge in developing dossiers that are fit for purpose.
As well as expertise in the US, the Prime Aventine team work closely with HEOR and evidence specialists in the wider global Evidence & Access team at Prime, to meet the needs of the changing US and global payer environment.
Sue O’Leary, BPharm
EVP, Evidence & Access
Sue O’Leary leads Prime’s Evidence & Access capability, bringing together a multidisciplinary team spanning market access, HEOR, real‑world evidence, and value strategy.
Sue began her career as a UK hospital pharmacist, managing formularies and developing an early appreciation for how healthcare decisions are made when resources are constrained. She later spent 15 years at AstraZeneca in global roles spanning pricing, market access, and early evidence planning, gaining experience during a period when health technology assessment and global‑to‑local alignment were reshaping the pharmaceutical landscape. These experiences shaped her belief that value must be built in from the outset of all development and commercialization decisions
At Prime, Sue focuses on creating strong connections between evidence generation, payer insight, clinical development and commercial strategy. Her role includes guiding teams across the US and Europe and aligning senior leaders in HEOR, RWE, US market access and global access. She works closely with colleagues across Prime’s capabilities to ensure clients have clear, actionable strategies grounded in robust, relevant evidence.
Megan Pollack, PharmD, BCOP
Vice President
Megan has both US market access value communications experience and clinical pharmacy experience that brings a unique perspective to Prime Aventine.
Prior to joining Prime Aventine, Megan served as Director of US Medical and Value Communications, where she was responsible for the delivery and oversight of AMCP dossiers, PIE slide decks, CMS dossiers, CMS IRA response documents, state-specific PDAB response documents, standard response documents, and publications (including abstracts, posters, and manuscripts) for a period of 9 years.
Megan’s direct experience in clinical pharmacy and laboratory bench research gives her deep insight into the full drug development process, from product development to post-approval market access and clinical product use.
Additionally, her experience in molecular biology has provided her with the ability to understand the complex landscape of companion diagnostics and diagnostic products in the US.
Megan has published research and review manuscripts in leading journals, including the Journal of Thoracic Oncology, Clinical Cancer Research, Lung Cancer, International Journal of Cancer, and Current Medical Research Opinion.
She earned her Doctorate of Pharmacy from the University of Florida, followed by a general pharmacy first-year residency and a second-year residency specializing in hematology/oncology at Vanderbilt University Medical Center.
Prior to pharmacy school, Megan earned a BSc in Molecular Biology from the University of West Florida and completed a post-baccalaureate Cancer Research Training Award fellowship at the National Institutes of Health, focusing on molecular biology and genetics research in lung cancer.
Rachel (Bongiorno) Karcher, PharmD
Director, Market Access
Rachel has years of experience critically evaluating and synthesizing drug information for varied audiences. Prior to joining Aventine, Rachel was Director of Educational Strategy and Content at a leading medical education company. In this role, Rachel managed medical writers and content managers, initiated the company’s publication strategy, developed innovative educational platforms, and strategized tactical educational plans for clients. Rachel was the lead content manager on projects that won the Alliance for Continuing Education in the Health Professions awards for outstanding research in CME and outstanding educational collaboration. Before moving into medical education, Rachel was Assistant Professor of Pharmacy and Director of Drug Information at the University of Maryland School of Pharmacy. At U of M, she was responsible for formulary management, developing and presenting formulary drug reviews, and evaluating and implementing cost-containment initiatives. During her tenure at U of M, Rachel also taught and managed both didactic and experiential pharmacy courses.
Rachel graduated magna cum laude with a Doctorate of Pharmacy from Northeastern University. After graduation, she completed a 1-year Drug Information Residency at the University of Arizona and a 1-year Pharmacy Practice Residency at the University of Illinois. Throughout her career, Rachel has authored numerous publications in peer-reviewed journals.
Dora Adami, PharmD
Director, Market Access
Dora brings her clinical knowledge, project management skills, and medical communications experience to Aventine. Prior to working with Aventine, Dora was Clinical Director for formulary submission dossiers and provided operations management at Strategic Pharmacy Innovations for 10 years. Dora also has direct experience in the pharmaceutical industry as a Clinical Supply Chain Coordinator at Pfizer, working on drug development projects ranging from Phase I to IV. Dora began her career at the Center for Infectious Disease Research in Seattle as a Project Manager for the development of a malaria vaccine. Over the course of her career, Dora has received several professional and team achievement awards, such as the Pharmaceutical Sciences Full Development Project Team Award (3 years), Personal Leadership and Supply Chain Recognition Awards.
Dora earned her Doctorate of Pharmacy from the University of Michigan, and served as a representative on the College of Pharmacy’s Board of Governors for several years. After receiving her PharmD, Dora completed a residency in Drug Information at Janssen. She graduated from the University of California, Berkeley with a Bachelor of Science in Molecular Cell Biology.
Founders
Holly (Carlton) Trautman, PharmD, MS
Co-Founder
Holly co-founded Aventine Consulting in 2008, which was wholly acquired by Prime Global in late 2023. At Aventine, Holly grew a successful company using her expertise in data evaluation, US payer market access insight, and strategic, evidence-based medical communication. She is no longer involved in day-to-day operations but remains committed to the continued success of Prime-Aventine as an advisor.
Prior to Aventine, Holly was Director of Clinical Services at Strategic Pharmacy Innovations where she orchestrated the development of formulary submission dossiers and impactful value statements for products over an extensive range of disease states. Previous to her career in consulting, Holly was the Director of Pharmacy at Community Health Plan of Washington, where she converted a pharmacy department in its infancy to a well-managed, evidence-based department through education and strong formulary management.
Holly received a Master of Science from the Pharmaceutical Outcomes Research and Policy Program (now the CHOICE Institute) at the University of Washington and a Doctorate of Pharmacy from the same university. She completed a fellowship in managed care pharmacy at Premera Blue Cross in Seattle. Holly earned her Bachelor of Arts from Hampshire College in Amherst, Massachusetts. She was the recipient of awards and scholarships throughout her training including the Facts and Comparisons’ award for excellence in clinical communication, several academic excellence scholarships, and a managed care fellowship.
Jamie (Clark) Dunning, PharmD
Co-Founder
Jamie co-founded Aventine Consulting in 2008, which was wholly acquired by Prime Global in late 2023. Jamie spent over 20 years of her successful career leading strategic market access communications and critically evaluating data to author evidence-based product value dossiers for US payers and the pharmaceutical/biotech industries. Jamie has invested her decades of institutional knowledge across a wide variety of pharma-client portfolios to strengthen Prime-Aventine and is enthusiastic about the continued success of the company she co-founded. She now advises Prime where needed to support Prime-Aventine’s evolution into the future.
Prior to founding Aventine, Jamie was an Associate Director of Clinical Services at Strategic Pharmacy Innovations developing formulary submission dossiers for the US payer audience, where she brought clinical depth in oncology and managed care systems. Prior to consulting, Jamie was Director of Pharmacy for a home infusion and specialty injectable company in Seattle. Her managed care career began in 1994 at Group Health Cooperative, where she was a clinical pharmacist for the hospital, the short-stay oncology infusion center, and the home infusion programs. While at Group Health, Jamie was also responsible for numerous formulary management projects. After years as a clinician, Jamie was recruited by Immunex (now Amgen) as a medical information pharmacist for their oncology and rheumatology products before embarking into the consulting industry.
Jamie earned her Doctorate of Pharmacy from the University of Colorado in Denver, where she received an Advanced Pharmacy Practice Experience Achievement Award for outstanding performance. She graduated with her 5-year Bachelor of Science in Pharmacy from the University of Washington School of Pharmacy and has been a registered pharmacist in the State of Washington since that time.